Carl KestensJan 9, 202214 min readTHE TEN BILLION DOLLAR UNICORN IN INMUNE BIO: PARTNERSHIP/BUYOUT AND VALUATION CONSIDERATIONS My views on possible partnership/buyout and valuation of INMB will be set out below. The highlights are the following. - I consider a...